This $4 Stock Could Be Your Ticket to Millionaire Status

What's the best next use of artificial intelligence (AI)? Plenty of people would say drug development. And they'd arguably be right.That's not something for down the road, though, when AI is more refined. Recursion Pharmaceuticals (NASDAQ: RXRX) is doing it right now. Its platform called Recursion OS leverages 65 petabytes (65 million gigabytes) of chemical and biological information to virtually test a drug.Clinical trials that would normally take years and millions of dollars to complete can now be done with a fraction of both. Although the FDA still requires full-blown clinical testing, this virtual pretesting allows pharmaceutical companies to focus their limited resources on only their most promising prospects.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool